Fat Grafting following Internal Tissue Expansion: An Option for Breast Reconstruction after Total Mastectomy
Kolasinski J., Pyka P.
Prospective Study with a reported sample of 11, published in Plast Reconstr Surg Glob Open (2022) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- Plast Reconstr Surg Glob Open (2022)
- Reported sample size
- 11
- Source database
- Europe PMC
- PMID
- 35169521
- PMCID
- PMC8835577
- DOI
- 10.1097/gox.0000000000004088
- Citations
- 6
Abstract (original English)
Background Breast reconstruction is currently performed as standard practice. Methods A prospective study was performed of patients after total mastectomy who underwent autologous breast reconstruction with fat grafting (FG) combined with internal tissue expansion between September 2015 and December 2020. The patients were classified into groups A to F depending on the steps of breast reconstruction. Groups A and B described patients with completed breast reconstruction with FG and expander removal, with or without nipple/areola complex reconstruction. C described patients during deflation of the expander combined with simultaneous FG. D described patients after expander implantation and refilling. E described patients after first FG, and F included patients who discontinued reconstruction with the described method and converted to reconstruction with a breast implant. Results Among 22 treated patients' two were after first FG (9.09%' group E), two were after expander implantation and refilling (9.09%' group D), three were during deflation of the expander combined with simultaneous FG (13.63%' group C), and four (18.18%) had completed breast reconstruction-two (9.09%) without NAC reconstruction and symmetrization (group B) and two (9.09%) with completed breast reconstruction (group A). In 11 patients (50%), breast reconstruction was abandoned after expander implantation and one
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.